";s:4:"text";s:3090:" Adverum Biotechnologies stock price forecast* for tomorrow, and next weeks based on the last 30 days. Start NOW! However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. All times are ET.
The expected earnings per share for the stock is -$0.28.The other major institutional holder is Avoro Capital Advisors LLC, with the holding of over 7.15 Million shares as of March 30, 2020. Further, we expressly disclaim any responsibility to update such research.
ADVM | Complete Adverum Biotechnologies Inc. stock news by MarketWatch. Click to get this free report Adverum Biotechnologies, Inc. (ADVM) : Free Stock Analysis Report To read this article on Zacks.com click here ...With this in mind, let’s examine the smart money sentiment towards Adverum Biotechnologies, Inc. (NASDAQ:ADVM) and determine whether hedge funds skillfully traded this stock. Following the latest results, Adverum Biotechnologies's five analysts are now forecasting revenues of US$568.0k in 2020.
Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. View ADVM revenue estimates and earnings estimates, as well as analyst recommendations. The 3-month trading volume is 1.33 Million shares.The consensus among analysts is that Adverum Biotechnologies, Inc. (ADVM) is a Buy stock at the moment, with a recommendation rating of 2.1. Past performance is not a guarantee of future results, and a loss of original capital may occur. All rights reserved. Most stock quote data provided by BATS. ADVM | Complete Adverum Biotechnologies Inc. stock news by MarketWatch. If we look at the company’s 10-day average daily trading volume, we find that it stood at 888.22 Million shares traded. Other than that, the company has, however, lowered its growth outlook for the 2020 fiscal year revenue.